Showing results (221-230 of 633) with videos related to
Sort By:
Pageof 64
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1983
Adenosine receptor binding: structure-activity analysis generates extremely potent xanthine antagonistsR F Bruns, J W Daly, S H SnyderBrain Research|May 5, 1979
Neurotensin-containing cell bodies, fibers and nerve terminals in the brain stem of the rat: immunohistochemical mappingG R Uhl, R R Goodman, S H SnyderAnnals of Neurology|March 1, 1987
Beyond receptors: multiple second-messenger systems in brainP F Worley, J M Baraban, S H SnyderBiochemical and Biophysical Research Communications|May 15, 1991
Nitric oxide synthase: irreversible inhibition by L-NG-nitroarginine in brain in vitro and in vivoM A Dwyer, D S Bredt, S H SnyderInvestigative Ophthalmology & Visual Science|October 1, 1989
Localization of angiotensin converting enzyme in the ciliary epithelium of the rat eyeS M Strittmatter, K M Braas, S H SnyderProceedings of the National Academy of Sciences of the United States of America|May 1, 1986
Atrial natriuretic factor receptors in rat kidney, adrenal gland, and brain: autoradiographic localization and fluid balance dependent changesD R Lynch, K M Braas, S H SnyderThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 1, 1986
Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidineA L Gundlach, B L Largent, S H SnyderEndocrinology|June 1, 1988
Enkephalin convertase in the heart: similar disposition to atrial natriuretic factorD R Lynch, J C Venable, S H SnyderLancet (London, England)|April 27, 1985
Normal MPTP binding in parkinsonian substantial nigra: evidence for extraneuronal toxin conversion in human brainG R Uhl, J A Javitch, S H SnyderJournal of Neurochemistry|February 1, 1987
Characterization of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, to neuromelaninR J D'Amato, D F Benham, S H SnyderPageof 64